Sort
48,018 grants matching “immunotherapy”
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$417,457Andrea Facciabene · University Of Pennsylvania · R01 · FY2016 · CA
Metabolic regulation of exosome biogenesis as a determinant of cancer cell metastasis.
$417,445Marc A Antonyak · Cornell University · R01 · FY2025 · CA
Metabolic regulation of exosome biogenesis as a determinant of cancer cell metastasis.
$417,445Marc A Antonyak · Cornell University · R01 · FY2022 · CA
STAFF INVESTIGATORS
$417,442Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2009 · CA
Chimeric CD80-SA as a Novel Cancer Vaccine
$417,413Rolf M Huseby · Apovax, Inc. · R43 · FY2006 · CA
Prediction and Prevention of Type I Diabetes
$417,406Dorothy J Becker · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2007 · DK
Biostatistics Facility
$417,377Hong Wang · University Of Pittsburgh At Pittsburgh · P30 · FY2025 · CA
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$417,345David J Mooney · Harvard University · R01 · FY2022 · CA
Subcellular enzyme-instructed self-assembly for molecular anticancer nanomedicines
$417,322Bing Xu · Brandeis University · R01 · FY2021 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$417,319Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer
$417,301Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA
Developing bispecific CAR Ts for treating AML
$417,244Xianxin Hua · University Of Pennsylvania · R21 · FY2020 · CA
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
$417,175Lena A. Basile · Neumedicines, Inc. · R44 · FY2016 · CA
How IL-10R blockade can resolve persistent viral infections
$417,170Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2009 · AI
How IL-10R blockade can resolve persistent viral infections
$417,170Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2008 · AI
Genetic and molecular mechanisms of replication of araC damaged DNA
$417,151Satya Prakash · University Of Texas Med Br Galveston · R01 · FY2016 · CA
Core D: Long-term Follow-Up
$417,131Stephanie J Lee · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
MOFLO TM MULTI-LASER FLOW CYTOMETER
$417,124University Of Connecticut Sch Of Med/Dnt · S10 · FY2000 · RR
Advanced development of composite gene delivery and CAR engineering systems
$417,077Sidi Chen · Yale University · R33 · FY2025 · CA
Advanced development of composite gene delivery and CAR engineering systems
$417,075Sidi Chen · Yale University · R33 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP CLINICAL TRIALS
$417,036Northwestern University · U10 · FY2001 · CA
Function of IL35+ B cells in pancreatic cancer
$417,022Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2025 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$417,003Qing Yi · Methodist Hospital Research Institute · R01 · FY2022 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$417,003Qing Yi · Methodist Hospital Research Institute · R01 · FY2023 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$416,987Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · AI